Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

Share Price is delayed by 15 minutes
Get Live Data
480.00    7.50 (1.59%)
Bid:
470.00
Ask:
490.00
Spread: 20.00 (4.255%)
Market Cap: £145.07m
EYE Live PriceLast checked at - London Stock Exchange

Intraday Eagle Eye Share Chart

AGM Trading Statement

19 Nov 2025 07:00

RNS Number : 0759I
Eagle Eye Solutions Group PLC
19 November 2025
Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

19 November 2025

Eagle Eye Solutions Group PLC

("Eagle Eye", the "Group" or the "Company")

Β 

AGM trading statement

Positive progress on all strategic objectives provides confidence in full year performance

Β 

Eagle Eye,Β a leading SaaS and AI technology company that creates digital connections enabling personalized, real-time marketing at scale, provides the following trading update ahead of the Company's Annual General Meeting ("AGM") to be held at 2.30 p.m. todayΒ atΒ the offices of x+why, The Orchard, Floor 8, One Great Cumberland Place, London, W1H 7AL.

Β 

Trading in H1 FY26 has started well, with new Wins in the UK, Thailand and notably in North America, where Eagle Eye has recently secured a new five-year contract with one of the largest independent food retailers, with the potential for expansion. Early progress from sharpened focus on the North American market is encouraging set against our strategic objective of winning in our biggest market, the USA. The pipeline continues to build, with an increasing number of well-progressed opportunities, demonstrating the growing traction of Eagle Eye's offering.

Β 

The Group is also pleased to report positive progress with its transformational OEM agreement, with both parties anticipating first customer contracts within the next few months. The launch event in October 2025 for the OEM's new loyalty solution was well attended; the solution is now live on the OEM's global price list and training of the OEM's global sales team is ongoing. The vendor's scale and extensive customer relationships mean the Board is confident this opportunity will add to Group ARR in FY26, with material revenue contribution from FY27 onwards.

Β 

As set out at the full year results, Eagle Eye is putting in place the foundations required to support sustained growth and margin progression, including operational and platform efficiencies, increased partner led delivery and the continued scale-up of its SaaS and AI revenue base. As part of this, the Group has made further adjustments to its operating structure to streamline its leadership. The Board is confident in maintaining a double-digit adjusted EBITDA margin for FY26 and improving adjusted EBITDA progression as the year progresses, with a target FY26 exit run rate EBITDA margin of 20%.

Β 

The Board remains confident in Eagle Eye's significant medium-term growth prospects, supported by continued strong momentum in EagleAI, expanding routes to market, and a scalable technology platform. With four new customer wins already this year and a healthy pipeline, alongside the structural changes undertaken and a strengthened leadership team, Eagle Eye is well positioned to deliver further positive momentum as it progresses through FY26, and for a return to double-digit revenue and EBITDA growth in FY27.

Β 

Enquiries:

Eagle Eye Solutions Group plc

Tel: 0844 824 3686

Tim Mason, Chief Executive Officer

Β 

Lucy Sharman-Munday, Chief Financial Officer

Β 

Β 

Β 

Investec Bank plc (Nominated Adviser and Joint Broker)

Tel: +44 20 7597 5970

David Anderson / Nick Prowting / James Smith

Β 

Β 

Β 

Shore Capital (Joint Broker)

Tel: +44 20 7408 4090

Corporate Advisory: Daniel Bush, David Coaten, Lucy Bowden

Β 

Corporate Broking: Henry Willcocks

Β 

Β 

Β 

Alma Strategic Communications

Tel: +44 20 3405 0205

Caroline Forde, Hannah Campbell, Kinvara Verdon

Β 

Β 

Β 

About Eagle Eye

Β 

Eagle Eye is a leading SaaS and AI company, enabling retail, travel and hospitality brands to earn lasting customer loyalty through harnessing the power of real-time, omnichannel and personalized marketing. Our powerful technology combines the world's most flexible and scalable loyalty and promotions capability with cutting edge, built-for-purpose AI to deliver 1:1 personalization at scale for enterprise businesses, globally.

Β 

Our growing customer base includes Loblaws, Southeastern Grocers, Giant Eagle, Asda, Tesco, Morrisons, JD Sports, E.Leclerc, Carrefour, the Woolworths Group and many more. Each week, more than 1 billion personalized offers are seamlessly executed via our platform, and over 700 million loyalty member wallets are managed worldwide.Β 

Β 

AI-powered, API-based and cloud-native, Eagle Eye's enterprise-grade technology is fully certified by the MACH Alliance and has received recognition from leading industry bodies, including Gartner, Forrester, IDC and QKS.Β 

Β 

Web - www.eagleeye.com

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMBPBBTMTIBTAA
Date   Source Headline
28th May 20267:00 amRNSSale of shares from treasury
21st May 20262:47 pmRNSPDMR shareholding & issue of equity - replacement
21st May 20261:35 pmRNSPDMR shareholding and issue of equity
21st May 20267:00 amRNSCapital Markets Day
27th Apr 20267:00 amRNSNotice of Capital Markets Day
24th Apr 202612:30 pmRNSPDMR Shareholding
23rd Apr 20268:11 amRNSPDMR shareholding and issue of equity
31st Mar 20262:02 pmRNSPCA Shareholding
20th Mar 202610:36 amRNSDirector/PDMR Shareholding
17th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20267:00 amRNSHalf Year Results
17th Mar 20267:00 amRNSHalf Year Results
6th Mar 20267:00 amRNSTransaction in Own Shares & Programme Completion
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20265:18 pmRNSNotification of major holdings
2nd Mar 20262:43 pmRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20263:32 pmRNSDirector/PDMR Shareholding
12th Feb 202610:59 amRNSDirector/PDMR Shareholding
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSExtension of Share Buyback Long Stop Expiry Date
29th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSAppointment of Nominated Adviser and Joint Broker
23rd Jan 20263:48 pmRNSDirector Declaration Update
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSMajor US multi-year contract win
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.